RENB

Lunai Bioworks Inc. RENB

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RENB ANGN MRNS LIANY IRD GRCE ALLK SER ORKA STSA
6M -60.56 % 23.21 % -60.43 % -78.07 % 120.90 % 12.33 % -68.66 % -57.04 % 173.13 % 19.57 %
YTD -81.39 % 14.69 % 3.00 % -66.84 % 61.90 % -15.75 % -73.46 % -52.16 % 60.84 % 27.63 %
1Y -73.70 % -10.71 % -76.29 % -64.03 % 96.15 % -6.39 % -71.63 % -53.35 % 52.01 % -77.51 %
3Y -93.00 % -94.12 % -70.11 % -94.24 % 58.14 % 11.96 % -88.29 % -87.58 % 16.89 % -96.07 %
5Y -95.34 % -94.12 % -58.96 % -99.34 % 58.14 % 11.96 % -99.55 % -95.88 % -37.02 % -93.49 %
10Y -97.59 % -94.12 % -94.72 % -99.34 % 58.14 % 11.96 % -98.95 % -97.48 % -97.15 % -93.49 %
From the beginning -97.59 % -94.12 % -93.13 % -99.34 % 58.14 % 11.96 % -98.95 % -97.48 % -100.00 % -93.49 %

Dividend

LianBio

Oruka Therapeutics, Inc.

Satsuma Pharmaceuticals, Inc.